Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
ARENA PHARMACEUTICALS INC (ARNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/21/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/16/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/16/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/16/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/16/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/11/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/11/2022 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
03/11/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/11/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/11/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/11/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/11/2022 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Arena Pharmaceuticals, Inc",
"Amended and Restated Bylaws of Arena Pharmaceuticals, Inc"
03/10/2022 SC 13G ARENA PHARMACEUTICALS INC reports a 23.1% stake in Longboard Pharmaceuticals, Inc.
03/10/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
03/10/2022 8-K Other Events  Interactive Data
02/23/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy